Page 3 - Proprietary Technology News Today

“Could we really tell during the pandemic, was this going to be a boon or a bust, post-pandemic? Nobody could, really.”

LXA, a technology startup focused on reimagining Asia's mortgage ecosystem, today announced the completion of its US$10 million seed funding round led by New Enterprise Associates, Inc. (NEA), with participation from Openspace Ventures and EDBI. Geared towards matching institutional capital pools and residential mortgage borrowers, this platform aims to utilize end-to-end technology to streamline the entire mortgage lifecycle, from loan origination and borrower processing to loan servicing.

KBR, Inc. (NYSE:KBR) Q3 2023 Earnings Call Transcript November 2, 2023 KBR, Inc. beats earnings expectations. Reported EPS is $0.75, expectations were $0.73. Operator: Hello all and welcome to KBR Inc’s Third Quarter 2023 Earnings Conference Call. My name is Lydia and I’ll be your operator today. [Operator Instructions] It’s my pleasure to now hand […]

Unveiling the Strengths and Challenges: A Deep Dive into LPL Financial Holdings Inc (LPLA) SWOT Analysis

An Australia-based company plans to build a campus in New Mexico to expand its research into hydrogen fuel as a heat source for industry, touting a proprietary chemical process without greenhouse gas emissions. Hydrogen-technology research and developer Star Scientific Limited, which has around 20 employees, signed a letter of intent with Gov. Michelle Lujan Grisham while she was in Sydney attending a summit Thursday on hydrogen and the energy sector.

The new formulation of the drug that was tested in the trial used Halozyme Therapeutics' proprietary technology, which allows large volumes of Opdivo, currently administered intravenously, to be delivered as an injection under the skin. "We believe this new option, given as a single injection administered in less than five minutes, could transform the treatment experience for both patients and physicians," Gina Fusaro, an executive at Bristol Myers Squibb, said.

RISC-V, pronounced as "risk five," is an open-source technology that competes with costly proprietary technology from British chip designer Arm Holdings. U.S. companies are still actively working to advance RISC-V based technology despite concerns expressed by lawmakers that China is exploiting a culture of open collaboration among American companies to advance its own semiconductor industry. Qualcomm said it plans to commercialize the RISC-V-based wearables solution globally includi...

Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The partners have signed a collaborative research agreement with the purpose of testing PCI Biotech’s proprietary technology for gene therapy manufacturing in the partners’ pilot manufacturing process. PCI Biotech brings its novel and promising technology for viral vector manufacturing ...

Allentown, Pennsylvania--(Newsfile Corp. - October 5, 2023) - Fake leads in mass torts cases pose a significant threat to the integrity of the leg...

In a new front in the U.S.-China tech war, President Joe Biden's administration is facing pressure from some lawmakers to restrict American companies from working on a freely available chip technology widely used in China - a move that could upend how the global technology industry collaborates across borders. At issue is RISC-V, pronounced "risk five," an open-source technology that competes with costly proprietary technology from British semiconductor and software design compan...